Data Factory
Reading the graph
Reading the graph
Private Equity
Stamford, CT
Inspired by opportunities. Guided by intellectual honesty.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| Viking Structured Capital (offshore 2 Intermediate) LP | 2024 | Unknown | Private Equity Fund | n/a | $148M | 0 |
| Viking Structured Capital (onshore) LP | 2023 | Early deployment | Private Equity Fund | n/a | $304M | 0 |
| Viking Structured Capital (offshore) LP | 2023 | Unknown | Private Equity Fund | n/a | $91.4M | 0 |
| Viking Structured Capital Sidecar (offshore 2) LP | 2023 | Unknown | Private Equity Fund | n/a | $137M | 0 |
| Viking Structured Capital Sidecar (offshore) LP | 2023 | Early deployment | Private Equity Fund | n/a | $120M | 0 |
| Viking Structured Capital Sidecar (onshore) LP | 2023 | Unknown | Private Equity Fund | n/a | $10.0M | 0 |
| Viking Global Opportunities Drawdown (onshore) LP | 2022 | Early deployment | Private Equity Fund | n/a | $1.1B | 0 |
| Viking Global Opportunities Drawdown (offshore) LP | 2022 | Early deployment | Private Equity Fund | n/a | $632M | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| Pursuing performance and operational excellence. | n/a | unknown | unknown | n/a | n/a | unknown |
| Our investment process | n/a | unknown | unknown | n/a | n/a | unknown |
| Public Equity | n/a | unknown | unknown | n/a | n/a | unknown |
| Private Equity | n/a | unknown | unknown | n/a | n/a | unknown |
| Credit & structured capital | n/a | unknown | unknown | n/a | n/a | unknown |
| Our investment principles | n/a | unknown | unknown | n/a | n/a | unknown |
| Strong collaboration between investment and operations teams | n/a | unknown | unknown | n/a | n/a | unknown |
| ESG integration | n/a | unknown | unknown | n/a | n/a | unknown |
| A disciplined approach to risk management | n/a | unknown | unknown | n/a | n/a | unknown |
| Required Cookies | n/a | unknown | unknown | n/a | n/a | unknown |
| Functional & Analytics Cookies | n/a | unknown | unknown | n/a | n/a | unknown |
| Apeel Sciences | n/a | unknown | unknown | n/a | n/a | active |
| 4D Molecular Therapeutics | n/a | unknown | unknown | n/a | n/a | active |
| AbCellera Biologics | n/a | unknown | unknown | n/a | n/a | active |
| Abdera Therapeutics | n/a | unknown | unknown | n/a | n/a | active |
| Adaptive Biotechnologies | n/a | unknown | unknown | n/a | n/a | active |
| Affinivax | n/a | unknown | unknown | n/a | n/a | active |
| Allonnia | n/a | unknown | unknown | n/a | n/a | active |
| AlphaSense | n/a | unknown | unknown | n/a | n/a | active |
| Altimmune | n/a | unknown | unknown | n/a | n/a | active |
| AmplifyBio | n/a | unknown | unknown | n/a | n/a | active |
| Amunix Pharmaceuticals | n/a | unknown | unknown | n/a | n/a | active |
| Amvkg | n/a | unknown | unknown | n/a | n/a | active |
| Amylyx Pharmaceuticals | n/a | unknown | unknown | n/a | n/a | active |
| Antheia | n/a | unknown | unknown | n/a | n/a | active |
| APi Group | n/a | unknown | unknown | n/a | n/a | active |
| Arcaea | n/a | unknown | unknown | n/a | n/a | active |
| Architect Therapeutics | n/a | unknown | unknown | n/a | n/a | active |
| Arctic Wolf | n/a | unknown | unknown | n/a | n/a | active |
| Areteia Therapeutics | n/a | unknown | unknown | n/a | n/a | active |
Also named here, with no published line of their own (reach them through the firm): David Truetzel (Managing Director), Hans Reuter (Managing Director), Max Lefcochilos-Fogelquist (Principal), Jonathan Fraga (Associate), Jason Rostovsky (Principal), Jon Coravos (Principal), Brandan Rivard (Managing Director), Levi Malik (Principal), Karim Helmy (Managing Director), Keith Johnson (Principal), Emily Nolop (Principal), Brian Rose (Deputy Head of Private Equity).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan